好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Pathogenic Variation in Fibrillin-2 Confers Susceptibility to Spontaneous Cerebrospinal Fluid Leaks Through Impairment of Cellular Adhesion
Headache
S35 - Hot Topics in Headache (1:48 PM-2:00 PM)
005

SsCSFLs have a strong association with connective tissue diseases (CTDs) including Marfan syndrome and Loeys-Dietz syndrome. Patients with ssCSFLs without specific diagnoses often have nonspecific CTD manifestations, suggesting that mutations in extracellular matrix proteins underlie more common presentations of this condition.

To investigate whether patients with spontaneous spinal cerebrospinal fluid leaks (ssCSFLs) have a higher frequency of rare variants in a single gene that could predispose them to this condition, and to study these variants' effects on cell function and dural homeostasis in mice.

Our case-control study of 49 Type 1b ssCSFL probands and 3 control groups (n = 2244, 1428, 1826) identified FBN2 as a top candidate gene. Recombinant WT and mutant fibrillin-2 fragments were synthesized using the Expi293 system and tested for human dural fibroblast binding and integrin involvement in vitro. Fbn2 variants were introduced in C57BL/6 mice using CRISPR-Cas9, which underwent lumbar infusion testing to determine dural integrity and resistance to rupture, with Fbn1C3041G/+ (Marfan syndrome model) as a positive control group. Single-nuclear RNA sequencing of mouse dura (n = 3-4 mice/group) was analyzed using Seurat in R.

We report a significantly increased burden of rare variants in FBN2 in patients with type 1b ssCSFLs. Two of these mutations reduce human dural fibroblast adhesion to fibrillin-2 fragments in vitro. One disrupts a known integrin binding motif in the TB4 domain; another affects a completely novel binding site in the TB7 domain. Mice harboring the fibrillin-2 TB4 variant (Fbn2D1581V/+) and a mouse model of Marfan syndrome (Fbn1C1041G/+) demonstrate a pronounced predisposition for dural rupture upon controlled leak induction. Single-nuclear RNA sequencing of Fbn2D1581V/+ and Fbn1C1041G/+ mouse dura demonstrates dysregulation of tropoelastin expression in dural fibroblasts.

These data suggest mutations in FBN2 that alter cellular adhesion and/or the synthetic repertoire of matrix elements may lead to increased susceptibility to ssCSFLs.

Authors/Disclosures
Cassie Parks
PRESENTER
Ms. Parks has nothing to disclose.
Mukti Singh, PhD Dr. Singh has nothing to disclose.
Elizabeth Wohler, MS Mrs. Wohler has nothing to disclose.
Renan Paulo Martin, PhD Dr. Paulo Martin has nothing to disclose.
Emily Juzwiak, PhD Dr. Juzwiak has nothing to disclose.
Xinyi Sun, MS Miss Sun has nothing to disclose.
Silke Peeters, PhD Mrs. Peeters has nothing to disclose.
Bart Loeys, MD, PhD Prof. Loeys has nothing to disclose.
Nara Sobreira, MD, PhD Dr. Sobreira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DASA. The institution of Dr. Sobreira has received research support from NIH.
Clair Baldock, PhD Prof. Baldock has received personal compensation in the range of $0-$499 for serving as a Consultant for Engitix. Prof. Baldock has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Matrix Biology, Elsevier. The institution of Prof. Baldock has received research support from BBSRC. The institution of Prof. Baldock has received research support from Wellcome.
Wouter Schievink, MD (Cedars Sinai Neurosurgical Inst) Dr. Schievink has nothing to disclose.
Harry Dietz, MD Dr. Dietz has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for AYTU. Dr. Dietz has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for GSK. Dr. Dietz has stock in GSK. Dr. Dietz has received intellectual property interests from a discovery or technology relating to health care.